Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: An association study with repeated assessment

International Journal of Neuropsychopharmacology

Volumn 7, Issue 4, 2004, Pages 489-493

  Lattuada, Enrico ^a   Cavallaro, Roberto ^a   Serretti, Alessandro ^a   Lorenzi, Cristina ^a,b   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dopamine receptor polymorphisms; Schizophrenia; Serotonin receptor polymorphisms; Tardive dyskinesia

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL ASPECT; TARDIVE DYSKINESIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DNA; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 10644270840     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004614     Document Type: Article

References (25)

1. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M (1994). Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343, 703-704.
2. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R (1995). Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346, 81-82.
3. Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Petronis A, Kennedy JL (2001). Lack of association between serotonin-2A receptor gene (HTR2A) polymorphism and tardive dyskinesia in schizophrenia. Molecular Psychiatry 6, 230-234.
4. Cavallaro R, Regazzetti MG, Mundo E, Brancato V, Smeraldi E (1993). Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence. Neuropsychopharmacology 8, 233-239.
5. Chen CH, Wei FU, Koong FJ, Hsiao KJ (1997). Association of Taq-I A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. Biological Psychiatry 41, 827-829.
6. Chong SA, Tan EC, Tan CH, Mythily, Chan YH (2003). Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia. American Journal of Medical Genetics 116, 51-54.
7. Cohen BM, Ennulat DJ, Centorrino F, Matthysse S, Konieczna H, Chu HM, Cherkerzian S (1999). Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology 141, 6-10.
8. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, Govea N, Mila M, Della Monica M, Ventruto V, De Benedetto M, Stanziale P, Zelante L, Mansfield ES, Sandkuijl L, Surrey S, Fortina P (1997). Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. European Journal of Human Genetics 5, 83-88.
9. Kane JM, Smith JM (1982). Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry 39, 473-481.
10. Lahiri DK, Nurnberger JI (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 19, 5444.
11. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, Sedvall G, Schwartz JC (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genetics 2, 249-256.
12. Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY, Kennedy JL, Steen VM, Macciardi F (2002). Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27, 105-119.
13. Ohara K, Nagai M, Tani K, Tsukamoto T, Ohara K (1999). Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Research 85, 221-224.
14. Rietschel M, Krauss H, Muller DJ, Schulze TG, Knapp M, Marwinski K, Maroldt AO, Paus S, Grunhage F, Propping P, Maier W, Held T, Nothen MM (2000). Dopamine D3 receptor variant and tardive dyskinesia. European Archives of Psychiatry and Clinical Neuroscience 250, 31-35.
15. Schooler NR, Kane JM (1982). Research diagnosis for tardive dyskinesia. Archives of General Psychiatry 39, 486-487.
16. Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafam M, Dorevitch A, Yakir A, Lerer A, Shelevoy A, Lerer B (1999). Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry 4, 247-253.
17. Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, Yakir A, Greenberg D, Strous R, Lerner A, Shelevoy A, Lerer B (2003). Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics 3, 277-283.
18. Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, Dorevitch A, Yakir A, Greenberg D, Lerner A, Lerer B (2001). Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry 6, 225-229.
19. Sham PC, Curtis D (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of Human Genetics 59, 97-105.
20. Simpson GM, Lee JH, Zoubok B, Gardos G (1979). A rating scale for tardive dyskinesia. Psychopharmacology 64, 171-179.
21. Steen VM, Lovlie R, MacEwan T, McCreadie RG (1997). Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Molecular Psychiatry 2, 139-145.
22. Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N (1990). Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102, 474-478.
23. Tan EC, Chong SA, Mahendran R, Dong F, Tan CH (2001). Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Biological Psychiatry 50, 144-147.
24. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991). Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-614.
25. Yassa R, Ananth J (1981). Familial tardive dyskinesia. American Journal of Psychiatry 138, 1618-1619.